Inani Marbles (531129)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹33.72 |
| Market Cap | ₹63.6 Cr |
| P/E Ratio | 0 |
| ROCE | 4.07% |
| ROE | -1.7% |
| Dividend Yield | 0.33% |
| Profit Growth | -135.71% |
| Debt/Equity | — |
| Sales Growth | -13.94% |
| 52-Week Range | ₹8.33 — ₹33.72 |
| Sector | Other Construction Materials |
| Book Value | ₹29.49 |
Strengths
- Trades close to book value at P/B of 1.14, with book value at ₹29.49 against price ₹33.72.
- ROCE is positive at 4.07%, indicating some operating capital efficiency despite weak ROE.
- Stock has recovered strongly from its 52-week low of ₹8.33, suggesting a possible shift in market sentiment.
- Latest quarter revenue of ₹9 crore with near-zero net loss may signal some stabilization after a steep profit decline.
Concerns
- Negative ROE of -1.70% and profit growth of -135.71% show the business is destroying value.
- Sales declined 13.94%, reflecting weak demand in a cyclical construction-linked industry.
- Piotroski F-score of only 3/9 points to poor financial health and operational deterioration.
- P/E is 0.00 due to no meaningful earnings, and the dividend yield of 0.33% offers little downside support.
AI Analysis
Let me start with what I can see. At ₹33.72 with a book value of ₹29.49, Inani Marbles sells at only 1.14 times book. But a low price-to-book is not enough. The business earned a negative return on equity of -1.70%, and profits fell by 135.71%, while sales contracted by 13.94%. Mr. Market may be excited by the stock's recovery from ₹8.33, but I prefer to celebrate earning power, and there is none here. The latest quarter shows sales of ₹9 crore and net profit of nearly zero — not a compounding machine. With a Piotroski F-score of 3 out of 9, financial health is weak. ROCE of 4.07% barely provides a return above the cost of capital after considering risk, and the dividend yield of 0.33% is negligible for a small-cap. Marble is essentially a commodity product tied to construction and real estate cycles. I do not see a durable competitive advantage or pricing power. This looks like an asset play, not a franchise. If I buy here, I am paying ₹33.72 for ₹29.49 of book value, hoping management can redeploy those assets into higher returns. So far, that hope is not supported by the numbers. Graham would demand a margin of safety; at 1.14 times book with negative earnings, the margin is thin. The lack of debt/equity and promoter holding data also makes the picture incomplete. I would keep this on the watchlist, not in my portfolio, until profitability improves and the sales decline stops. Watch return on equity, sales trends, and capital allocation closely before acting.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer